Nanoencapsulation and characterization of zidovudine on poly(L-lactide) and poly(L-lactide)-poly(ethylene glycol)-blend nanoparticles

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 11, 2012, Pages 8513-8521

  Mainardes, Rubiana Mara ^a   Gremião, Maria Palmira Daflon ^b  

^a UNIVERSIDADE ESTADUAL DO CENTRO OESTE   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Biodegradable polymers; Drug delivery; Nanoparticles; PLA; PLA PEG; Zidovudine

Indexed keywords

ANTIRETROVIRALS; DRUG ENCAPSULATION EFFICIENCY; MEAN DIAMETER; NANO-ENCAPSULATION; PHYSICAL MIXTURES; PHYSICOCHEMICAL CHARACTERISTICS; PHYSICOCHEMICAL PARAMETERS; PLA; PLA-PEG; POLY (L-LACTIDE); RELEASE RATE; ZIDOVUDINE;

BIODEGRADABLE POLYMERS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; INFRARED SPECTROSCOPY; ORGANIC SOLVENTS; POLYETHYLENE GLYCOLS; SCANNING ELECTRON MICROSCOPY;

NANOPARTICLES;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LACTIC ACID DERIVATIVE; MACROGOL DERIVATIVE; NANOCAPSULE; POLY(LACTIC ACID ETHYLENE GLYCOL); POLY(LACTIC ACID-ETHYLENE GLYCOL); ZIDOVUDINE;

ARTICLE; CHEMISTRY; DIFFUSION; MATERIALS TESTING; ULTRASTRUCTURE;

ANTI-HIV AGENTS; DIFFUSION; LACTATES; MATERIALS TESTING; NANOCAPSULES; POLYETHYLENE GLYCOLS; ZIDOVUDINE;

MLCS; MLOWN;

EID: 84871857463     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6638     Document Type: Article

References (40)

1. F. C. Carvalho, R. M. Mainardes, and M. P. D Gremião, Understanding HIV/AIDS Management and Care-Pandemic Approaches in the 21st Century, edited by F. H. Kasenga, InTech, Croatia (2011), p. 367.
2. E. De Clercq, Int. J. Antimicrob. Agents 33, 307 (2007).
3. M. R. Blum, S. H. T. Liao, S. S. Good, and P. Miranda, Am. J. Med. 85, 189 (1988).
4. O. Barbier, D. Turgeon, C. Girard, M. D. Green, T. R. Tephly, D. W. Hum, and A. Bélanger, Drug Metab. Dispos. 28, 497 (2000).
5. G. J. Veal and D. J. Back, Gen. Pharmacol. 26, 1469 (1995).
6. G. D'Andrea, F. Brisdelli, and A. Bozzi, Curr. Clin. Pharmacol. 3, 20 (2008).
7. Y. R. Freund, L. Dousman E. S. Riccio, B. Sato, J. T. MacGregor, and N. Mohagheghpour, Int. Immunopharmacol. 1, 2131 (2001).
8. S. R. Gogu, J. S. Malter, and K. C. Agrawal, Biochem. Pharmacol. 44, 1009 (1992).
9. P. Sharma and S. Garg, Adv. Drug Deliv. Rev. 62, 491 (2010).
10. E. Ojewole, I. Mackraj, P. Naidoo, and T. Govender, Eur. J. Pharm. Biopharm. 70, 697 (2008).
11. A. Sosnik, D. A. Chiappetta, and A. M. Carcaboso, J Control Release 138, 2 (2009).
12. A. R. Bender, V. Schäfer, A. M. Steffan, C. Royer, J. Kreuter, H. Rubsamen-Waigmann, and H. von Briesen, Res. Virol. 145, 215 (1994).
13. A. R. Bender, H. von Briesen, J. Kreuter, I. B. Duncan, and H. Rubsamen-Waigmann, Antimicrob. Agents Chemother. 40, 1467 (1996).
14. V. Schäfer, H. von Briesen, R. Andreesen, A. M. Steffan, C. Royer, S. Troster, J. Kreuter, and H. Rubsamen-Waigmann, Pharm. Rev. 9, 541 (1992).
15. C. J. Destache, T. Belgum, K. Christensen, A. Shibata, A. Sharma, and A. Dash, BMC Infect. Dis. 9, 198 (2009).
16. H. L. Wong, N. Chattopadhyay, X. Y. Wu, and R. Bendayan, Adv. Drug Deliv. Rev. 62, 503 (2010).
17. N. M. Khalil, E. Carraro, L. F. Cótica, and R. M. Mainardes, Expert Opin. Drug Deliv. 8, 95 (2011).
18. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, J.-E., and J.-P. Benoit, Biomaterials 24, 4283 (2003).
19. M. F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M. J. Alonso, P. Labrud, and C. Vigneron, J. Control. Release 50, 31 (1998).
20. A. Lamprecht, N. Ubrich, M. H. Perez, C.-M. Lehr, M. Hoffman, and P. Maincent, Int. J. Pharm. 196, 177 (2000).
21. R. Alex and R. Bodmeier, J. Microencapsul. 7, 347 (1989).
22. A. Kumari, S. K. Yadav, and S. C. Yadav, Colloids Surf. B Biointer. 75, 1 (2010).
23. Y. C. Dong and S. S. Feng, Biomaterials 25, 2843 (2004).
24. R. Gref, A. Domb, P. Quellec, T. Blunk, R. H. Muller, J. M. Verbavatz, and R. Langer, Adv. Drug Deliv. Rev. 16, 215 (1995).
25. S. Stolnik, S. E. Dunn, M. C. Garnett, M. C. Davies, A. G. A. Coombes, D. C. Taylor, M. P. Irving, S. C. Purkiss, T. F. Tadros, S. S. Davis, and L. Illum, Pharm Res. 11, 1800 (1994).
26. J. Jansen, X. Song, and D. E. Brooks, Biophys. J. 70, 313 (1996).
27. D. Giron, J. Therm. Anal. Calorim. 68, 335 (2002).
28. N. Markovic, S. A. Kustrin, B. A. Glass, and C. A. Prestidge, J. Pharm. Biomed. Anal. 42, 25 (2006).
29. J. C. Jeong, J. Lee, and K. Cho, J. Control Release 92, 249 (2003).
30. A. A. Ambike, K. R. Mahadik, and A. Paradkar, Int. J. Pharm. 282, 151 (2004).
31. M. Ohtaa and G. Bucktona, Int. J. Pharm. 289, 31 (2005).
32. B. Siekmann and K. Westesen, Colloids Surfaces B 3, 159 (1994).
33. R. M. Mainardes, M. P. D. Gremião, and R. C. Evangelista, Braz. J. Pharm. Sci. 42, 523 (2006).
34. S. Vyazovkin and I. Dranca, J. Phys. Chem. B 109, 18637 (2005).
35. A. G. Hausberg and P. P. Deluca, J. Pharm. Biomed. Anal. 13, 747 (1995).
36. J. Matsumoto, Y. Nakada, K. Sakurai, T. Nakamura, and Y. Takahashi, Int. J. Pharm. 185, 93 (1999).
37. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Control Release 25, 89 (1993).
38. M. T. Peracchia, R. Gref, Y. Minamitake, A. Domb, N. Lotan, and R. Langer, J. Control Release 46, 223 (1997).
39. J. Siepmann, N. Faisant, J. Akiki, J. Richard, and J.-P. Benoit, J. Control Release 96, 123 (2004).
40. S. Sant, V. Nadeau, and P. Hildgen, J. Control. Release 107, 203 (2005).